#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cytokine release syndrome Scleroderma associated digital ulcer Selective polysaccharide antibody deficiency Neuronal ceroid lipofuscinosis Carcinoid syndrome Pulmonary hypertension Epileptic encephalopathy Chronic inflammatory demyelinating polyradiculoneuropathy Liposarcoma recurrent Hypophosphatasia Eosinophilic granulomatosis with polyangiitis Hepatocellular carcinoma Rheumatoid arthritis Pulmonary tuberculosis Bulbospinal muscular atrophy congenital More trials…

    Learn about Rare Diseases

    Aicardi-Goutieres syndrome – Trials in Disease Hyperoxaluria – Basic Information Hepatoblastoma Cystic fibrosis lung – Diagnostics Hepatic angiosarcoma – Basic Information Mantle cell lymphoma refractory – Diagnostics Congenital nephrogenic diabetes insipidus – Trials in Disease Ocular melanoma – Treatment Friedreich’s ataxia – Diagnostics Ehlers-Danlos syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Vb10.16 Gemcitabine Hydrochloride INOBRODIB ZIMISLECEL Perindopril Arginine Pitolisant Iptacopan Hydrochloride Dimeticone MAGNESIUM CARBONATE HEAVY Omp65 Varenicline Cldn6 Rna-Lpx Iodixanol 534 Exl01 Niflumic Acid Tpst-1120 RP3 Glofitamab Amisulpride More therapies…

    Learn about Your Condition

    Ovarian granulosa cell tumour Cholestatic pruritus Crohn's disease Deafness traumatic Loeys-Dietz syndrome Perinatal depression Noninfective chorioretinitis Tooth loss Vesicoureteric reflux Epidermolysis bullosa Tumour thrombosis Nephroblastoma Tachypnoea Breast cancer female Rhabdomyosarcoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Major depression

  • Study on Esketamine and Propofol for Anesthesia in Electroconvulsive Therapy for Patients with Major Depression

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Major depression
    Investigated Drugs:
    • Methohexital Sodium
    • Esketamine Hydrochloride
    • Propofol
    Austria

  • Study on the Effects of Psilocybin (COMP360) for Adults with Treatment-Resistant Depression

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Psilocybine
    Czechia Denmark France Germany Ireland The Netherlands +3

  • Study on the Long-term Use of Pramipexole for Patients with Anhedonic Depression

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Pramipexole
    Sweden

  • Study on Celecoxib for Reducing Symptoms in Adults with Major Depressive Disorder and Immuno-metabolic Characteristics

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Celecoxib
    The Netherlands

  • Study on the Effects of Mebufotenin (GH001) for Patients with Treatment-Resistant Depression

    Not recruiting

    2 1
    Investigated Diseases:
    • Major depression
    Investigated Drugs:
    • Mebufotenin
    Czechia Germany Ireland Poland Spain

  • Study on Aticaprant for Adults with Major Depressive Disorder and Anhedonia Not Responding to Antidepressants

    Not recruiting

    3 1
    Investigated Diseases:
    • Major depression
    Investigated Drugs:
    • Aticaprant
    Belgium Bulgaria Czechia Finland Hungary Poland +2
Previous Page
1 … 7 8 9

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!